Cost savings in migraine associated with less chest pain on new triptan therapy.

The American journal of managed care

Volumn 8, Issue 3 Suppl, 2002, Pages

  Wang, Joseph T ^a   Barr, Charles E ^a   Torigoe, Yas ^a   Wang, Elaine ^a   Rowland, Clayton R ^a   Goldfarb, Scott D ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALMOTRIPTAN; INDOLE DERIVATIVE; SEROTONIN AGONIST; SUMATRIPTAN; TRYPTAMINE DERIVATIVE;

ARTICLE; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; COST CONTROL; ECONOMICS; FEMALE; HUMAN; INFORMATION PROCESSING; MALE; MIGRAINE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; THORAX PAIN; UNITED STATES;

CHEST PAIN; COHORT STUDIES; COST SAVINGS; COST-BENEFIT ANALYSIS; DATA COLLECTION; FEMALE; HUMANS; INDOLES; MALE; MIGRAINE DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; SEROTONIN AGONISTS; SUMATRIPTAN; TRYPTAMINES; UNITED STATES;

EID: 0036484947     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)